✦ LIBER ✦

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

✍ Scribed by Joanna M. Brell; Smitha S. Krishnamurthi; Milind Javle; Joel Saltzman; Ira Wollner; Robert Pelley; Afshin Dowlati; Belagodu N. Kantharaj; Mark D. Schluchter; Linda Rath; S. Percy Ivy; Scot C. Remick

Publisher: Springer
Year: 2008
Tongue: English
Weight: 277 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0807-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CPT-11 plus cisplatin in patients with a

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma : Results of a Phase II study

✍ Jaffer A. Ajani; Jackie Baker; Peter W. T. Pisters; Linus Ho; Paul F. Mansfield; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma

✍ Eileen M. O'Reilly; Keith E. Stuart; Pedro M. Sanz-Altamira; Gary K. Schwartz; C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Phase-II study of dose attenuated schedu

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer

✍ Bassel F. El-Rayes; Mark M. Zalupski; Stephanie G. Manza; Barbara Rusin; Ann Mar 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 304 KB

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

✍ Karim Fizazi; Frédéric Rolland; Christine Chevreau; Jean-Pierre Droz; Dominique 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

## Abstract ## BACKGROUND Patients with disseminated renal cell carcinoma (RCC) have a poor outcome, and the disease is considered highly resistant to chemotherapy. Irinotecan is an active drug in the treatment of a number of neoplastic diseases and is not concerned with the multidrug‐resistance p

A multiple-center phase II study of week

A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

✍ Jen-Shi Chen; Yen-Yang Chen; Jen-Sheng Huang; Kun-Yun Yeh; Ping-Tsung Chen; Wen- 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB

A multiple-center phase II study of biwe

A multiple-center phase II study of biweekly oxaliplatin and tegafur–uracil/leucovorin for chemonaive patients with advanced gastric cancer

✍ Jen-Shi Chen; Kun-Ming Rau; Yen-Yang Chen; Jen-Seng Huang; Tsai-Shen Yang; Yung- 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 276 KB